Clinical Trials Logo

Clinical Trial Summary

Vascular evaluation of candidates to living kidney donation is important because there is an increased risk of end stage renal disease and cardiovascular disease after donation. The implication of vascular remodeling in the vascular morbidity observed in donors has not been established because the parameters of vascular remodeling in donors have so far been poorly described. The object of the present study is to study the evolution of vascular remodeling of small, medium and large vessels (until then not evaluable by standard techniques) before and one year after living kidney donation, by dedicated-, non invasive-examinations, which results are associated with cardiovascular risk in the general population. This approach will make it possible to precisely assess the impact of unilateral nephrectomy on vascular remodeling after living donation and to estimate the change in cardiovascular risk attributable to the donation. These results will also help refine the assessment of candidates for kidney donation and potentially open up new strategies to improve selection process of candidates to living kidney donation. Of note, we also plan to evaluate one year after the first exploration potentiel living kidney donors who did not give their kidney due to medical or non medical reasons, as a control group.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05073913
Study type Interventional
Source Assistance Publique - Hôpitaux de Paris
Contact Marie COURBEBAISSE, MD, PhD
Phone +33 1 56 09 39 69
Email marie.courbebaisse@aphp.fr
Status Recruiting
Phase N/A
Start date May 10, 2022
Completion date March 2026

See also
  Status Clinical Trial Phase
Completed NCT00936078 - The Living Kidney Donor Safety Study
Not yet recruiting NCT04791670 - eHealth Usability in Living Kidney Donation